Advertisement
Screener

VERU INC. (VERU) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount

2.2 / 5 stars · 40/89 Roast Me

VERU INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount

VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $52.05 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-08-10

  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2026-06-30 was $52.05K, a 10.48% decline year-over-year.
  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2026-03-31 was $18.95K, a 4.67% decline year-over-year.
  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2025-12-31 was $1.65K, a 123.27% increase year-over-year.
  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2025-09-30 was $51.84K, a 10611.36% increase year-over-year.
  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $130.61K, a 3991.67% increase from fiscal 2024.
  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $3.19K, a 99.03% decline from fiscal 2023.
  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $330.28K.
  • VERU INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2015 was $51.00K.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month as first filedEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 6 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 6 month as first filedEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 9 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 9 month as first filedEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed
2026-06-30$52.05K
10-Q · filed 2026-08-10
$71.00K
derived: sum of 2 quarters · filed 2026-08-10
$72.65K
10-Q · filed 2026-08-10
$124.49K
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$18.95K
10-Q · filed 2026-05-13
$20.60K
10-Q · filed 2026-05-13
$72.44K
derived: sum of 3 quarters · filed 2026-05-13
$130.59K
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$1.65K
10-Q · filed 2026-02-11
$53.49K
derived: sum of 2 quarters · filed 2026-02-11
$111.64K
derived: sum of 3 quarters · filed 2026-08-10
$131.52K
derived: sum of 4 quarters · filed 2026-08-10
2025-09-30$51.84K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17
$109.99K
derived: sum of 2 quarters · filed 2026-08-10
$129.87K
derived: sum of 3 quarters · filed 2026-08-10
$130.61K
10-K · filed 2025-12-17
2025-06-30$58.15K
10-Q · filed 2026-08-10
$78.02K
derived: sum of 2 quarters · filed 2026-08-10
$78.76K
10-Q · filed 2026-08-10
$79.25K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$19.87K
10-Q · filed 2026-05-13
$20.61K
10-Q · filed 2026-05-13
$21.10K
derived: sum of 3 quarters · filed 2026-05-13
$23.10K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$739.00
10-Q · filed 2026-02-11
$1.22K
derived: sum of 2 quarters · filed 2026-02-11
$3.22K
derived: sum of 3 quarters · filed 2026-02-11
$3.82K
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30$484.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17
$2.48K
derived: sum of 2 quarters · filed 2025-12-17
$3.08K
derived: sum of 3 quarters · filed 2025-12-17
$3.19K
10-K · filed 2025-12-17
$200.23K
10-K · filed 2024-12-16
2024-06-30$2.00K
10-Q · filed 2025-08-12
$30.04K
10-Q · filed 2024-08-08
$2.60K
derived: sum of 2 quarters · filed 2025-08-12
$2.71K
10-Q · filed 2025-08-12
$291.06K
10-Q · filed 2024-08-08
$147.43K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$596.00
10-Q · filed 2025-05-08
$171.61K
10-Q · filed 2024-05-08
$708.00
10-Q · filed 2025-05-08
$261.02K
10-Q · filed 2024-05-08
$145.43K
derived: sum of 3 quarters · filed 2025-05-08
-$116.58K
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$112.00
10-Q · filed 2025-02-13
$89.41K
10-Q · filed 2024-04-01
$144.83K
derived: sum of 2 quarters · filed 2025-02-13
-$117.18K
derived: sum of 3 quarters · filed 2025-02-13
$216.94K
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30$144.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16
-$117.29K
derived: sum of 2 quarters · filed 2024-12-16
$216.82K
derived: sum of 3 quarters · filed 2024-12-16
$330.28K
10-K · filed 2024-12-16
2023-06-30-$262.00K
10-Q · filed 2024-08-08
$72.11K
derived: sum of 2 quarters · filed 2024-08-08
$185.56K
10-Q · filed 2024-08-08
2023-03-31$334.11K
10-Q · filed 2024-05-08
$447.57K
10-Q · filed 2024-05-08
2022-12-31$113.46K
10-Q · filed 2024-04-01
2022-06-30-$355.07K
10-Q/A · filed 2023-11-15
-$252.34K
derived: sum of 2 quarters · filed 2023-11-15
$4.86K
10-Q/A · filed 2023-11-15
2022-03-31$102.73K
10-Q · filed 2023-05-11
$359.93K
10-Q · filed 2023-05-11
2021-12-31$257.20K
10-Q · filed 2023-02-09
2021-06-30-$2.81K
10-Q · filed 2022-08-11
-$2.81K
10-Q · filed 2022-08-11
2020-06-30$332.23K
10-Q · filed 2021-08-12
$335.87K
10-Q · filed 2021-08-12
2019-06-30$2.27K
10-Q · filed 2020-08-13
$7.05K
10-Q · filed 2020-08-13
2017-06-30$29.00K
10-Q · filed 2018-08-14
$71.00K
derived: sum of 2 quarters · filed 2018-08-14
$182.00K
10-Q · filed 2018-08-14
2017-03-31$42.00K
10-Q · filed 2018-05-11
$153.00K
10-Q · filed 2018-05-11
2016-12-31$111.00K
10-Q · filed 2018-02-14
2016-06-30$1.00K
10-Q · filed 2017-08-09
$2.00K
derived: sum of 2 quarters · filed 2017-08-09
$4.00K
10-Q · filed 2017-08-09
$52.00K
derived: sum of 4 quarters · filed 2017-08-09
2016-03-31$1.00K
10-Q · filed 2017-05-10
$3.00K
10-Q · filed 2017-05-10
$51.00K
derived: sum of 3 quarters · filed 2017-05-10
$52.00K
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$2.00K
10-Q · filed 2016-02-02
$50.00K
derived: sum of 2 quarters · filed 2016-02-02
$51.00K
derived: sum of 3 quarters · filed 2016-07-28
$51.00K
derived: sum of 4 quarters · filed 2016-07-28
2015-09-30$48.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02
$49.00K
derived: sum of 2 quarters · filed 2016-07-28
$49.00K
derived: sum of 3 quarters · filed 2016-07-28
$51.00K
10-K · filed 2015-12-02
2015-06-30$1.00K
10-Q · filed 2016-07-28
$1.00K
derived: sum of 2 quarters · filed 2016-07-28
$3.00K
10-Q · filed 2016-07-28
-$5.00K
derived: sum of 4 quarters · filed 2016-07-28
2015-03-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-28
$2.00K
10-Q · filed 2016-04-28
-$6.00K
derived: sum of 3 quarters · filed 2016-04-28
-$5.00K
derived: sum of 4 quarters · filed 2016-04-28
2014-12-31$2.00K
10-Q · filed 2016-02-02
-$6.00K
derived: sum of 2 quarters · filed 2016-02-02
-$5.00K
derived: sum of 3 quarters · filed 2016-02-02
-$5.00K
derived: sum of 4 quarters · filed 2016-02-02
2014-09-30-$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02
-$7.00K
derived: sum of 2 quarters · filed 2015-12-02
-$7.00K
derived: sum of 3 quarters · filed 2015-12-02
-$5.00K
10-K · filed 2015-12-02
2014-06-30$1.00K
10-Q · filed 2015-07-30
$1.00K
derived: sum of 2 quarters · filed 2015-07-30
$3.00K
10-Q · filed 2015-07-30
$124.00K
derived: sum of 4 quarters · filed 2015-12-02
2014-03-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-30
$2.00K
10-Q · filed 2015-04-30
$123.00K
derived: sum of 3 quarters · filed 2015-12-02
$124.00K
derived: sum of 4 quarters · filed 2015-12-02
2013-12-31$2.00K
10-Q · filed 2015-02-03
$123.00K
derived: sum of 2 quarters · filed 2015-12-02
$124.00K
derived: sum of 3 quarters · filed 2015-12-02
$126.00K
derived: sum of 4 quarters · filed 2015-12-02
2013-09-30$121.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02
$122.00K
derived: sum of 2 quarters · filed 2015-12-02
$124.00K
derived: sum of 3 quarters · filed 2015-12-02
$129.00K
10-K · filed 2015-12-02
2013-06-30$1.00K
10-Q · filed 2014-07-31
$3.00K
derived: sum of 2 quarters · filed 2014-07-31
$8.00K
10-Q · filed 2014-07-31
$8.00K
derived: sum of 4 quarters · filed 2014-12-02
2013-03-31$2.00K
10-Q · filed 2014-05-01
$7.00K
10-Q · filed 2014-05-01
$7.00K
derived: sum of 3 quarters · filed 2014-12-02
$9.00K
derived: sum of 4 quarters · filed 2014-12-02
2012-12-31$5.00K
10-Q · filed 2014-02-03
$5.00K
derived: sum of 2 quarters · filed 2014-12-02
$7.00K
derived: sum of 3 quarters · filed 2014-12-02
$8.00K
derived: sum of 4 quarters · filed 2014-12-02
2012-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02
$2.00K
derived: sum of 2 quarters · filed 2014-12-02
$3.00K
derived: sum of 3 quarters · filed 2014-12-02
$5.00K
10-K · filed 2014-12-02
2012-06-30$2.00K
10-Q · filed 2013-08-01
$3.00K
derived: sum of 2 quarters · filed 2013-08-01
$5.00K
10-Q · filed 2013-08-01
-$9.00K
derived: sum of 4 quarters · filed 2013-12-03
2012-03-31$1.00K
10-Q · filed 2013-05-02
$3.00K
10-Q · filed 2013-05-02
-$11.00K
derived: sum of 3 quarters · filed 2013-12-03
-$10.00K
derived: sum of 4 quarters · filed 2013-12-03
2011-12-31$2.00K
10-Q · filed 2013-01-30
-$12.00K
derived: sum of 2 quarters · filed 2013-12-03
-$11.00K
derived: sum of 3 quarters · filed 2013-12-03
2011-09-30-$14.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03
-$13.00K
derived: sum of 2 quarters · filed 2013-12-03
-$12.00K
10-K · filed 2013-12-03
2011-06-30$1.00K
10-Q · filed 2012-07-31
$2.00K
10-Q · filed 2012-07-31
2010-09-30$305.00K
10-K · filed 2012-12-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34